Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience (2022) Dreger P, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner E, Wulf G, et al. Journal article Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al. Journal article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Acute And Chronic Graft-Versus-Host-Disease Impair B-Cell Reconstitution in Allogeneic-Transplanted Patients at Different Maturation Stages (2021) Fante MA, Weigert V, Hoffmann P, Fehn U, Winkler T, Winkler J, Herr W, et al. Conference contribution The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease (2020) Qayed M, Kapoor U, Gillespie S, Mccracken C, Abusin G, Aguayo-Hiraldo P, Ayuk F, et al. Conference contribution Incidence of Secondary Malignancies After TBI/VP16 Conditioning for Childhood All - Results of the Prospective ALL-SCT-BFM-2003 Trial (2020) Eichinger A, Glogova E, Beier R, Guengoer T, Stachel D, Stachel D, Lang P, et al. Conference contribution The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations (2020) Heidrich K, Middeke JM, Schaefer-Eckart K, Aulitzky WE, Einsele H, Mueller-Tidow C, Rösler W, et al. Conference contribution Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies (2020) Kalwak K, Mielcarek M, Patrick K, Styczynski J, Bader P, Corbacioglu S, Burkhardt B, et al. Journal article 1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation (2020) Peter K, Siska PJ, Roider T, Matos C, Bruns H, Renner K, Singer K, et al. Journal article